Skip to content

Hi-Aspect Ltd

Request correction

Corporate brand

Unclaimed

New Zealand biotechnology startup developing protein nanofibril materials for personal care and wound healing.

Last updated September 29, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Hi-Aspect Ltd is a New Zealand biotechnology startup founded in 2015 by Professor Juliet Gerrard FRSNZ, a leading New Zealand biochemist, together with her research team. The company is built around a proprietary platform of protein nanofibril technology — microscopic, insoluble protein materials derived from natural sources. These nanofibrils have a high surface area and a range of properties that make them valuable in skin care, cosmetics, wound care and other life science applications. Hi-Aspect specialises in developing protein-based materials and products for the medical and life science markets. Its technology platform is being commercialised into two principal application areas. In personal care, the company offers a safe, natural gel that can replace traditional stabilisers and emulsifiers, providing an appealing silky feel, variable properties and controlled release of active ingredients. In wound healing, it is developing a protein nanofibril gel that stabilises and tethers bioactive compounds to the site of healing to bring the greatest benefit to patients. The company draws on the expertise of some of the best scientists in New Zealand to guide its research agendas, and it has an experienced management team and a high-quality board. Its board includes Jennifer Anderson as Executive Director, responsible for day-to-day running of the company and managing the research and development programmes that drive new product development; Elizabeth Hopkins as Independent Chair, a specialist in scientific commercialisation and pharmaceutical and biotechnology management; and Steve Silvey as Director, an Investment Director at Oxford University and Chartered Accountant who supports the strategic and financial direction of the company. The management team also includes Theresa Donnelly in financials and administration. As a privately held early-stage company, Hi-Aspect is focused on further developing its protein nanofibril technology and bringing new products to the skincare and wound healing markets. It operates from New Zealand and targets global medical and life science markets.

History

Hi-Aspect Ltd was founded in 2015 in New Zealand by Professor Juliet Gerrard FRSNZ, a leading New Zealand biochemist, together with her world-class research team. The founding was based on the invention of a range of revolutionary materials using protein nanofibril technology. Professor Gerrard and her team developed microscopic nanofibrils derived from natural sources, which possess a high surface area and a range of properties valuable in skin care, cosmetic and wound care arenas. From its inception, the company specialised in developing protein-based materials and products for the medical and life science markets. It established a platform around protein nanofibrils — an insoluble protein material with applications in personal care, cosmetics, wound healing and other areas. The company then focused on translating this platform into commercial products, particularly a natural gel for personal care that can replace traditional stabilisers and emulsifiers, and a protein nanofibril gel for wound healing that stabilises and tethers bioactive compounds to the site of healing. Hi-Aspect has built an experienced management team and a high-quality board to guide its development. The board includes Jennifer Anderson as Executive Director, Elizabeth Hopkins as Independent Chair, and Steve Silvey as Director. The management team includes Theresa Donnelly in financials and administration. The company draws on the expertise of some of the best in New Zealand science to guide its research agendas. As a privately held startup, Hi-Aspect continues to further develop its technology and bring new products to the skincare and wound healing markets. It operates from New Zealand and addresses global medical and life science markets.

  • 2015

    Hi-Aspect Ltd founded in New Zealand by Professor Juliet Gerrard FRSNZ and her team.

  • Development of protein nanofibril technology platform for personal care and wound healing.

Products and positioning

Developer of natural, protein-based advanced materials for personal care, cosmetics and wound healing, leveraging New Zealand scientific expertise.

  • Protein Nanofibrils

    A high surface area, insoluble protein material with applications in personal care, cosmetics, wound healing and other areas.

  • Personal Care Gel

    A safe, natural gel that can replace traditional stabilisers and emulsifiers, with an appealing silky feel, variable properties and controlled release of active ingredients.

  • Wound Healing Gel

    A protein nanofibril gel that stabilises and tethers bioactive compounds to the site of healing to bring the greatest benefit to patients.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/hi-aspect-ltd · Editorial policy · How profiles are compiled